AMANDA FRASER: Open Payments
NPI 1518135748 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 89 payments from 18 companies in 2025. Trend: 2023 $1,772 · 2024 $2,102 · 2025 $1,792
Food & beverage: $1,639Education: $135Consulting: $18
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 23 | $526 |
| AstraZeneca Pharmaceuticals LP | 21 | $401 |
| PFIZER INC. | 7 | $151 |
| Grifols USA, LLC | 5 | $99 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Amgen Inc. | 2 | $56 |
| CSL Behring | 3 | $53 |
| Organon LLC | 6 | $49 |
Products named: DUPIXENT, TEZSPIRE, CIBINQO, AIRSUPRA, NUCALA, Rhapsido, FASENRA, Xembify.
Industry payments across NC — which companies pay providers there.
